Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback